Cytosorbents Crp (CTSO)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from CTSO's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Cytosorbents Crp's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $43M | $35M | $31M | $36M | $37M |
| Net income | -$25M | -$33M | -$29M | -$21M | -$8M |
| Free cash flow | -$18M | -$34M | -$22M | -$15M | -$13M |
| EPS (diluted) | -$0.57 | -$0.75 | -$0.65 | -$0.38 | -$0.13 |
| Operating margin | -52.7% | -90.9% | -102.8% | -46.2% | -39.8% |
Where the revenue comes from
Revenue by products, fiscal 2023. Every breakdown, year by year.
Superinvestors who own CTSO
From each investor's latest 13F filing (what a 13F shows).
Insider buying
Open-market purchases by Cytosorbents Crp's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Alan D. Sobel Director |
100 | $6.01 | $601 |
| Sep 15, 2026 | Alan D. Sobel Director |
1,900 | $6.12 | $11,628 |
| Sep 15, 2026 | Alan D. Sobel Director |
500 | $6.05 | $3,025 |
| Sep 15, 2026 | Phillip P. Chan Chief Executive Officer |
3,774 | $6.00 | $22,644 |
| Sep 14, 2026 | Vincent Capponi President and COO |
1,800 | $6.07 | $10,926 |
| Sep 14, 2026 | Vincent Capponi President and COO |
273 | $5.90 | $1,611 |
| Sep 4, 2026 | Phillip P. Chan Chief Executive Officer |
200,000 | $0.35 | $70,000 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CTSO trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Cytosorbents Crp insiders buying the stock?
7 open-market insider purchases of CTSO in the last 12 months, from SEC Form 4 filings.
Companies like Cytosorbents Crp
All Healthcare stocks · Medical Devices stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.